Correlation Between TITANIUM TRANSPORTGROUP and Akebia Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TITANIUM TRANSPORTGROUP and Akebia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TITANIUM TRANSPORTGROUP and Akebia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TITANIUM TRANSPORTGROUP and Akebia Therapeutics, you can compare the effects of market volatilities on TITANIUM TRANSPORTGROUP and Akebia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TITANIUM TRANSPORTGROUP with a short position of Akebia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TITANIUM TRANSPORTGROUP and Akebia Therapeutics.

Diversification Opportunities for TITANIUM TRANSPORTGROUP and Akebia Therapeutics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between TITANIUM and Akebia is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding TITANIUM TRANSPORTGROUP and Akebia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Therapeutics and TITANIUM TRANSPORTGROUP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TITANIUM TRANSPORTGROUP are associated (or correlated) with Akebia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Therapeutics has no effect on the direction of TITANIUM TRANSPORTGROUP i.e., TITANIUM TRANSPORTGROUP and Akebia Therapeutics go up and down completely randomly.

Pair Corralation between TITANIUM TRANSPORTGROUP and Akebia Therapeutics

Assuming the 90 days horizon TITANIUM TRANSPORTGROUP is expected to generate 0.82 times more return on investment than Akebia Therapeutics. However, TITANIUM TRANSPORTGROUP is 1.21 times less risky than Akebia Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Akebia Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  148.00  in TITANIUM TRANSPORTGROUP on September 14, 2024 and sell it today you would earn a total of  7.00  from holding TITANIUM TRANSPORTGROUP or generate 4.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

TITANIUM TRANSPORTGROUP  vs.  Akebia Therapeutics

 Performance 
       Timeline  
TITANIUM TRANSPORTGROUP 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in TITANIUM TRANSPORTGROUP are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, TITANIUM TRANSPORTGROUP may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Akebia Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Akebia Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

TITANIUM TRANSPORTGROUP and Akebia Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TITANIUM TRANSPORTGROUP and Akebia Therapeutics

The main advantage of trading using opposite TITANIUM TRANSPORTGROUP and Akebia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TITANIUM TRANSPORTGROUP position performs unexpectedly, Akebia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Therapeutics will offset losses from the drop in Akebia Therapeutics' long position.
The idea behind TITANIUM TRANSPORTGROUP and Akebia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world